Schizophrenia Research
Volume 120, Issue 1 , Pages 42-48, July 2010

Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: An empirical question

  • Lawrence H. Yang

      Affiliations

    • Columbia University, Department of Epidemiology, School of Public Health, 722 West 168th Street, Room 1610, New York, NY 10032, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 305 4747; fax: +1 212 342 5169.
  • ,
  • Ahtoy J. Wonpat-Borja

      Affiliations

    • Columbia University, Department of Epidemiology, School of Public Health, 722 West 168th Street, Room 1610, New York, NY 10032, United States
  • ,
  • Mark G. Opler

      Affiliations

    • New York University, Department of Psychiatry, United States
    • New York University, Department of Environmental Medicine, United States
  • ,
  • Cheryl M. Corcoran

      Affiliations

    • Columbia University, Department of Psychiatry, United States

Received 24 September 2009; received in revised form 5 February 2010; accepted 12 March 2010. published online 20 April 2010.

Abstract 

While the “clinical high-risk state” for psychosis has demonstrated good reliability and fair predictive validity for psychotic disorders, over 50% of identified subjects do not progress to psychosis. Despite the benefits that early detection and treatment might offer, debate concerning the official inclusion of a “psychosis risk syndrome” in the upcoming DSM-V frequently involves concerns about the impact of stigma on patients, families and institutions. We add to this debate by providing an analysis of the theoretical and empirical stigma literature to evaluate the potential effects of stigma associated with the psychosis risk syndrome. Theorists' conceptualizations of how stigma exerts its negative effects emphasize internalization of pejorative societal stereotypes (‘self-stigma’), negative emotional reactions, harmful behavioral coping strategies, and structural discrimination as key mechanisms. Studies assessing the comparative effects of symptomatic behavior when compared with a psychiatric diagnosis label in predicting rejecting social attitudes indicate that treating symptomatic behaviors is likely to diminish overall stigma. However, any publically held ‘preexisting conceptions’ about what a psychosis risk syndrome means are still likely to exert negative effects. Additionally, particular features of this syndrome—that it occurs during adolescence when identity formation may be in flux— may also shape manifestations of stigma. Utilizing other well-established ‘at-risk’ conditions (e.g., genetic susceptibility) to model potential discrimination for this syndrome, we suggest that future discrimination is likely to occur in insurance and family domains. We conclude by proposing stigma measurement strategies, including recommending that field trials prior to DSM-V adopt systematic measures to assess any stigma that this psychosis risk syndrome might confer via future community use.

Keywords: Stigma, Psychosis, Prodrome, Discrimination, Adolescents, Schizophrenia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(10)01182-5

doi:10.1016/j.schres.2010.03.012

Schizophrenia Research
Volume 120, Issue 1 , Pages 42-48, July 2010